These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 15248918

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
    Fajkusová L, Fajkus J, Polácková K, Fulnecek J, Dvoráková D, Krahulcová E.
    Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
    [Abstract] [Full Text] [Related]

  • 3. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ, Liu YR, Li JL, Wang H, Chang Y, Fu JY, Ruan GR, Shi HL, Qiu JY, Lu DP, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
    [Abstract] [Full Text] [Related]

  • 4. [Polymorphisms in the breakpoint cluster region of bcr gene].
    Tian H, Zhou SY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):659-62. PubMed ID: 18549649
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of sequence-tagged site in bcr and abl genes by DNA pooling and dHPLC].
    Tian H, Liu DM, Xu B, Zheng WY, Zhou SY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):468-71. PubMed ID: 15972144
    [Abstract] [Full Text] [Related]

  • 6. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu, Turkina AG, Misiurin AV, Aksenova EV, Domracheva EV, Zakharova AV, Khoroshko ND.
    Ter Arkh; 2007 Jun; 79(4):49-53. PubMed ID: 17564019
    [Abstract] [Full Text] [Related]

  • 7. Detection of bcr-abl gene expression at a low level in blood cells of some patients with essential thrombocythemia.
    Hsu HC, Tan LY, Au LC, Lee YM, Lieu CH, Tsai WH, You JY, Liu MD, Ho CK.
    J Lab Clin Med; 2004 Feb; 143(2):125-9. PubMed ID: 14966468
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An atypical (b3/a3) junction of the bcr/abl gene lacking abl exon a2 in a patient with chronic myeloid leukemia.
    Amabile M, Martinelli G, Terragna C, Montefusco V, Tabilio A, Tura S.
    Haematologica; 1999 Jun; 84(6):573-5. PubMed ID: 10366813
    [No Abstract] [Full Text] [Related]

  • 10. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence.
    Sugimoto T, Ijima K, Hisatomi H, Murayama T, Mizuno I, Hato A, Imoto S, Nishimura R, Koizumi T.
    Am J Hematol; 2004 Oct; 77(2):164-6. PubMed ID: 15389825
    [Abstract] [Full Text] [Related]

  • 11. [Construction and expression of a vector containing protein transduction domain and bcr/abl fusion gene].
    Liang Y, Sun Q, Jiang S, Wang J, Wu R, Chen P, Liu L, Han H.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):5-8. PubMed ID: 12015079
    [Abstract] [Full Text] [Related]

  • 12. Identification and structural comparison of deleterious mutations in nsSNPs of ABL1 gene in chronic myeloid leukemia: a bio-informatics study.
    George Priya Doss C, Sudandiradoss C, Rajasekaran R, Purohit R, Ramanathan K, Sethumadhavan R.
    J Biomed Inform; 2008 Aug; 41(4):607-12. PubMed ID: 18243808
    [Abstract] [Full Text] [Related]

  • 13. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
    Meng WT, Liu T, Li JJ, Shi Q, Yu J, Cui X, Wu Y, Xiang B.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653
    [Abstract] [Full Text] [Related]

  • 14. Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl.
    Gutiérrez-Berzal J, Castellano E, Martín-Encabo S, Gutiérrez-Cianca N, Hernández JM, Santos E, Guerrero C.
    Exp Cell Res; 2006 Apr 01; 312(6):938-48. PubMed ID: 16443220
    [Abstract] [Full Text] [Related]

  • 15. [Study on mismatch repair genes of chronic myeloid leukemia].
    Luo J, Peng ZG, Chen Y, Lai YR, Lu YY, Song SJ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb 01; 27(2):103-6. PubMed ID: 16732964
    [Abstract] [Full Text] [Related]

  • 16. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
    Wang S, Chai YB, Liu F, Zhang XY, Jia W, Xie X, Yu WQ, Shang ZC, Jin BQ, Sun BZ.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 19; 85(3):198-202. PubMed ID: 15854468
    [Abstract] [Full Text] [Related]

  • 17. [CML with mu-BCR/ABL mRNA: clinical characteristics of our three cases and 26 reported cases].
    Ito T.
    Rinsho Ketsueki; 2003 Apr 19; 44(4):234-41. PubMed ID: 12784656
    [No Abstract] [Full Text] [Related]

  • 18. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M, Brajuskovic G, Strelic N, Todoric-Zivanovic B, Stamatovic D, Tatomirovic Z, Magic Z.
    J BUON; 2008 Apr 19; 13(3):403-8. PubMed ID: 18979557
    [Abstract] [Full Text] [Related]

  • 19. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P.
    Acta Haematol; 2009 Apr 19; 122(1):11-6. PubMed ID: 19641300
    [Abstract] [Full Text] [Related]

  • 20. Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.
    Martinelli G, Zaccaria A, Farabegoli P, Buzzi M, Testoni N, Bragliani M, Panzica G, Tura S.
    Leuk Lymphoma; 1993 Apr 19; 11 Suppl 1():51-6. PubMed ID: 8251917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.